I
INDV
Indivior Pharmaceuticals Inc.
40.65
-0.65-1.57%Opening14:54 07/10 EDT
OPEN/PREV CLOSE41.14/41.30
TODAY RANGE40.00-41.16
VOL788.77K
MARKET CAP4.96B
52 WEEK RANGE14.93-42.81
AVG VOL (3M)1.98M
% TURNOVER0.65%
TURNOVER--
P/E (TTM)20.99
% RANGE2.81%
EPS(TTM)1.937
P/E(FORWARD)12.80
P/B-34.4404
BVPS-1.1803
DIVIDEND--
P/S4.101
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.75B
SHARES OUTSTANDING121.92M
NEXT EARNINGS07/29-08/03
FREE FLOAT116.75M
LOT SIZE1
EX-DATE10/11/2022
News
Press Releases
Financial Reports
Profile
Seeking Alpha·4h ago
Q2 watchlist: Healthcare stocks with perfect EPS revision scores
Simply Wall St·1d ago
How Indivior’s Multi-Index Russell 2000 Defensive Inclusion (INDV) Has Changed Its Investment Story
Simply Wall St·2d ago
Is Indivior Pharmaceuticals (INDV) Fully Valued As Russell 2000 Index Additions Draw Buyers?
NASDAQ·06/29 08:18
5 Biotech Stocks That Skyrocketed 105% To 235% — TWST, INDV, MIRM & More
NASDAQ·06/29 08:00
Bull of the Day: Neurocrine Biosciences (NBIX)
Simply Wall St·06/29 04:31
Does Indivior (INDV) Joining Multiple Russell 2000 Defensive Indices Recast Its Opioid-Treatment Narrative?
NASDAQ·06/26 14:43
IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati
NASDAQ·06/26 08:59
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
Simply Wall St·06/26 01:19
Indivior Pharmaceuticals (INDV) Pushes Cost Cuts And Growth, Is It Still 17% Undervalued?
NASDAQ·06/25 12:40
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
NASDAQ·06/23 15:07
NVO Gains as Foundation Unveils EUR 60M Cardiometabolic Research Push
NASDAQ·06/19 14:35
BEAM Stock Gains 5% as FDA Clears BEAM-304 IND for Phenylketonuria
NASDAQ·06/19 14:24
PFE Stock Slides Following CFO Exit, 2026 Guidance Reaffirmed
NASDAQ·06/19 13:16
Teva Seeks FDA Nod for Ecopipam in Pediatric Tourette Syndrome
NASDAQ·06/19 12:14
Can Vertex's Kidney Pipeline Power Its Next Growth Phase?
Same Industry
Name/Symbol
Change%
Price